A Phase 1 Study of JMT108 in Participants With Advanced Solid Tumors
NCT07317505
·
clinicaltrials.gov ↗
PHASE1
Phase
RECRUITING
Status
270
Enrollment
INDUSTRY
Sponsor class
Conditions
Cancer
Cancer (Solid Tumors)
Interventions
DRUG:
JMT108
Sponsor
Conjupro Biotherapeutics, Inc.